AgingResearch.News
Frontiers in Immunology

Everolimus-based immunosuppression induces alloreactive regulatory T cell expansion combined with loss of alloreactive effector T cells

By Nicolle H. R. Litjens, Jip Jonker, Mariska Klepper, Show 7 more authorsMichiel G.H. Betjes
Trial in peopleInterventions
Paper

The paper

Nicolle H. R. Litjens, Jip Jonker, Mariska Klepper, Show 7 more authorsMichiel G.H. Betjes

Erasmus MC

Frontiers in Immunology, 3 Aug 2026

doi.org/10.3389/fimmu.2026.1904559PubMed 42609864

Related